| Heading: |
Medical Equipment: Prices |
| Question ID: |
1789530 |
| UIN: |
42142 |
| House: |
Commons |
| Date tabled: |
2025-03-27 |
| Asking Member ID: |
5339 |
| Asking Member display name: |
Danny Beales
|
| Asking Member handle: |
DannyBeales
|
| Asking Member Twitter reference: |
@DannyBeales
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of NICE’s Late Stage Assessments on the attractiveness of the UK for inward investment from medtech companies. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-04 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department commissioned the National Institute for Health and Care Excellence (NICE) to undertake Late-Stage Assessments (LSAs) to help commissioners, clinicians, and patients identify the most effective products that offer the best value for the Nati... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |